Richard Christopher
2022 - InVivo Therapeutics Holdings
In 2022, Richard Christopher earned a total compensation of $583.8K as Chief Financial Officer at InVivo Therapeutics Holdings, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $147,768 |
|---|---|
| Option Awards | $45,964 |
| Salary | $369,420 |
| Other | $20,628 |
| Total | $583,780 |
Christopher received $369.4K in salary, accounting for 63% of the total pay in 2022.
Christopher also received $147.8K in bonus, $46K in option awards and $20.6K in other compensation.
Rankings
In 2022, Richard Christopher's compensation ranked 4,010th out of 5,506 executives tracked by ExecPay. In other words, Christopher earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,010 out of 5,506 | 27th |
Division Manufacturing | 2,255 out of 2,985 | 25th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 293 out of 458 | 36th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 209 out of 325 | 36th |
Industry Surgical and Medical Instruments and Apparatus | 159 out of 239 | 34th |
Source: SEC filing on December 5, 2023.
Christopher's colleagues
We found two more compensation records of executives who worked with Richard Christopher at InVivo Therapeutics Holdings in 2022.
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020